Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA-DNA hybrid ribonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

9.90e-1011955GO:0004523
GeneOntologyMolecularFunctionRNA-directed DNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.24e-0914955GO:0003964
GeneOntologyMolecularFunctionaspartic-type endopeptidase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25

2.04e-0837956GO:0004190
GeneOntologyMolecularFunctionaspartic-type peptidase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25

2.41e-0838956GO:0070001
GeneOntologyMolecularFunctionRNA stem-loop binding

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.20e-0821955GO:0035613
GeneOntologyMolecularFunctiontranscription coregulator activity

BCL9L NUP98 GON4L ZMIZ1 DCC RUNX1T1 MED15 KMT2C PER2 SMARCC2 RERE TRIM13 TOX2 FOXP3

4.20e-075629514GO:0003712
GeneOntologyMolecularFunctionRNA endonuclease activity, producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

8.47e-0737955GO:0016891
GeneOntologyMolecularFunctionDNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

9.72e-0738955GO:0034061
GeneOntologyMolecularFunctiontranscription coactivator activity

BCL9L NUP98 ZMIZ1 DCC KMT2C PER2 SMARCC2 RERE TRIM13 TOX2

1.81e-063039510GO:0003713
GeneOntologyMolecularFunctionendonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

2.57e-0646955GO:0016893
GeneOntologyMolecularFunctionchromatin binding

SOX9 EP400 NUP98 SREBF1 SMC4 NCAPH PHF21A NFIA ANKRD17 SMARCC2 RERE MBD5 TOX2 FOXC1

1.02e-057399514GO:0003682
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

BCL9L GATAD2A RBM33 NUP98 GON4L ZMIZ1 DCC RUNX1T1 MED15 KMT2C PER2 GAB3 SMARCC2 RERE TRIM13 TOX2 FOXP3

3.01e-0511609517GO:0030674
GeneOntologyMolecularFunctionRNA endonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

3.74e-0579955GO:0004521
GeneOntologyMolecularFunctionmolecular adaptor activity

BCL9L GATAD2A SASH1 RBM33 NUP98 GON4L ZMIZ1 DCC RUNX1T1 MED15 KMT2C PER2 GAB3 SMARCC2 RERE TRIM13 TOX2 FOXP3

6.23e-0513569518GO:0060090
GeneOntologyMolecularFunctionphosphatidylinositol-3,5-bisphosphate 5-phosphatase activity

OCRL SYNJ2

3.32e-046952GO:0043813
GeneOntologyMolecularFunctioninositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity

OCRL SYNJ2

4.63e-047952GO:0052659
GeneOntologyMolecularFunctionRNA nuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.83e-04136955GO:0004540
GeneOntologyMolecularFunctionendonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.83e-04136955GO:0004519
GeneOntologyMolecularFunctionhistone H3K4 monomethyltransferase activity

KMT2B KMT2C

6.16e-048952GO:0140945
GeneOntologyMolecularFunctioninositol-1,4,5-trisphosphate 5-phosphatase activity

OCRL SYNJ2

6.16e-048952GO:0052658
GeneOntologyMolecularFunctioninositol tetrakisphosphate phosphatase activity

OCRL SYNJ2

7.89e-049952GO:0052743
GeneOntologyMolecularFunctionnucleotidyltransferase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

7.99e-04152955GO:0016779
GeneOntologyMolecularFunctionphosphatidylinositol-4,5-bisphosphate 5-phosphatase activity

OCRL SYNJ2

9.83e-0410952GO:0004439
GeneOntologyMolecularFunctionphosphatidylinositol phosphate 4-phosphatase activity

OCRL SYNJ2

9.83e-0410952GO:0034596
GeneOntologyMolecularFunctionhistone H3K4 trimethyltransferase activity

KMT2B KMT2C

9.83e-0410952GO:0140999
GeneOntologyMolecularFunctionendopeptidase activity

ERVK-6 CLCA4 ERVK-7 ERVK-10 F12 ERVK-8 ERVK-18 ERVK-25

1.03e-03430958GO:0004175
GeneOntologyMolecularFunctionphosphatidylinositol-4,5-bisphosphate phosphatase activity

OCRL SYNJ2

1.43e-0312952GO:0106019
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

ERVK-6 EP400 ERVK-7 ERVK-10 ERVK-8 ERVK-11

1.58e-03262956GO:0140097
GeneOntologyMolecularFunctionphosphatidylinositol phosphate 5-phosphatase activity

OCRL SYNJ2

1.69e-0313952GO:0034595
GeneOntologyMolecularFunctioninositol trisphosphate phosphatase activity

OCRL SYNJ2

1.96e-0314952GO:0046030
GeneOntologyMolecularFunctionphosphatidylinositol-3,5-bisphosphate phosphatase activity

OCRL SYNJ2

2.57e-0316952GO:0106018
GeneOntologyMolecularFunctionpeptidase activity

ERVK-6 CLCA4 NUP98 ERVK-7 ERVK-10 F12 ERVK-8 ERVK-18 ERVK-25

3.94e-03654959GO:0008233
GeneOntologyMolecularFunctioninositol phosphate phosphatase activity

OCRL SYNJ2

4.02e-0320952GO:0052745
GeneOntologyMolecularFunctionhistone H3K4 methyltransferase activity

KMT2B KMT2C

4.02e-0320952GO:0042800
GeneOntologyMolecularFunctionSH3 domain binding

CBLB ARHGAP1 AFAP1 SYNJ2

4.85e-03143954GO:0017124
GeneOntologyMolecularFunctionnuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.95e-03231955GO:0004518
GeneOntologyBiologicalProcessDNA integration

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

2.46e-0913965GO:0015074
GeneOntologyBiologicalProcessDNA synthesis involved in DNA repair

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

2.87e-0648965GO:0000731
GeneOntologyBiologicalProcessRNA-templated DNA biosynthetic process

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11

4.29e-0583965GO:0006278
GeneOntologyBiologicalProcessspinal cord ventral commissure morphogenesis

DCC ADARB1

6.41e-053962GO:0021965
GeneOntologyBiologicalProcessDNA replication

ERVK-6 ERVK-7 ERVK-10 NFIA ERVK-8 ANKRD17 ERVK-11 INO80E

1.05e-04312968GO:0006260
GeneOntologyCellularComponentSWI/SNF superfamily-type complex

GATAD2A EP400 GON4L SMARCC2 INO80E

7.31e-0596945GO:0070603
GeneOntologyCellularComponentINO80-type complex

EP400 GON4L INO80E

2.66e-0428943GO:0097346
GeneOntologyCellularComponentATPase complex

GATAD2A EP400 GON4L SMARCC2 INO80E

2.93e-04129945GO:1904949
GeneOntologyCellularComponentcondensin complex

SMC4 NCAPH

5.50e-048942GO:0000796
GeneOntologyCellularComponenthistone deacetylase complex

GATAD2A EP400 PHF21A RERE

5.88e-0485944GO:0000118
GeneOntologyCellularComponentnuclear periphery

NUP98 RUNX1T1 PRR14 SMARCC2 ALOX5

1.05e-03171945GO:0034399
GeneOntologyCellularComponentnuclear protein-containing complex

BCL9L KMT2B GATAD2A EP400 NUP98 WDR83 GON4L PHF21A MED15 KMT2C PER2 SMARCC2 RERE CCDC9 INO80E

1.19e-0313779415GO:0140513
DomainMYB_LIKE

EP400 GON4L SMARCC2 RERE

2.87e-0538874PS50090
DomainSANT

EP400 GON4L SMARCC2 RERE

8.59e-0550874SM00717
DomainSANT/Myb

EP400 GON4L SMARCC2 RERE

1.00e-0452874IPR001005
DomainFYrich_C

KMT2B KMT2C

2.13e-045872IPR003889
DomainFYrich_N

KMT2B KMT2C

2.13e-045872IPR003888
DomainFYRC

KMT2B KMT2C

2.13e-045872SM00542
DomainFYRN

KMT2B KMT2C

2.13e-045872SM00541
DomainFYRN

KMT2B KMT2C

2.13e-045872PF05964
DomainFYRC

KMT2B KMT2C

2.13e-045872PF05965
DomainFYRC

KMT2B KMT2C

2.13e-045872PS51543
DomainFYRN

KMT2B KMT2C

2.13e-045872PS51542
Domain-

KMT2B DIDO1 ZMIZ1 CBLB PHF21A KMT2C DZIP3 FGD1 TRIM13

2.42e-044498793.30.40.10
DomainAT_hook

KMT2B PHF21A KMT2C

2.63e-0427873SM00384
DomainAT_hook_DNA-bd_motif

KMT2B PHF21A KMT2C

2.63e-0427873IPR017956
DomainZnf_RING/FYVE/PHD

KMT2B DIDO1 ZMIZ1 CBLB PHF21A KMT2C DZIP3 FGD1 TRIM13

2.84e-04459879IPR013083
DomainMyb-like_dom

EP400 GON4L

3.18e-046872IPR017877
DomainPHD

KMT2B DIDO1 PHF21A KMT2C

4.15e-0475874PF00628
DomainZnf_PHD-finger

KMT2B DIDO1 PHF21A KMT2C

5.06e-0479874IPR019787
DomainZnf_FYVE_PHD

KMT2B DIDO1 PHF21A KMT2C FGD1

6.21e-04147875IPR011011
DomainPH

RAPH1 PHETA1 ASAP1 AFAP1 FGD1 GAB3

7.03e-04229876PF00169
DomainPHD

KMT2B DIDO1 PHF21A KMT2C

7.93e-0489874SM00249
DomainZnf_PHD

KMT2B DIDO1 PHF21A KMT2C

8.62e-0491874IPR001965
DomainIPPc

OCRL SYNJ2

9.42e-0410872IPR000300
DomainIPPc

OCRL SYNJ2

9.42e-0410872SM00128
DomainZF_PHD_2

KMT2B DIDO1 PHF21A KMT2C

1.01e-0395874PS50016
DomainZF_PHD_1

KMT2B DIDO1 PHF21A KMT2C

1.05e-0396874PS01359
DomainSAM_2

SASH1 PPFIA4 LCP2

1.05e-0343873PF07647
DomainPH

RAPH1 PHETA1 ASAP1 AFAP1 FGD1 GAB3

1.90e-03278876SM00233
DomainHMG_box

SOX9 KMT2C TOX2

1.93e-0353873PF00505
DomainPH_DOMAIN

RAPH1 PHETA1 ASAP1 AFAP1 FGD1 GAB3

1.93e-03279876PS50003
DomainPH_domain

RAPH1 PHETA1 ASAP1 AFAP1 FGD1 GAB3

1.97e-03280876IPR001849
DomainHMG

SOX9 KMT2C TOX2

2.04e-0354873SM00398
DomainZnf_GATA

GATAD2A RERE

2.17e-0315872IPR000679
DomainGATA

GATAD2A RERE

2.17e-0315872PF00320
Domain-

RAPH1 PHETA1 PTPN21 ASAP1 AFAP1 FGD1 GAB3

2.32e-033918772.30.29.30
DomainPost-SET_dom

KMT2B KMT2C

2.47e-0316872IPR003616
DomainGATA_ZN_FINGER_1

GATAD2A RERE

2.47e-0316872PS00344
DomainPostSET

KMT2B KMT2C

2.47e-0316872SM00508
DomainGATA_ZN_FINGER_2

GATAD2A RERE

2.47e-0316872PS50114
DomainAT_hook

PHF21A KMT2C

2.47e-0316872PF02178
DomainPOST_SET

KMT2B KMT2C

2.47e-0316872PS50868
DomainRhoGAP

ARHGAP32 OCRL ARHGAP1

3.03e-0362873SM00324
DomainRhoGAP

ARHGAP32 OCRL ARHGAP1

3.17e-0363873PF00620
DomainRHOGAP

ARHGAP32 OCRL ARHGAP1

3.31e-0364873PS50238
DomainRhoGAP_dom

ARHGAP32 OCRL ARHGAP1

3.31e-0364873IPR000198
Domain-

ARHGAP32 OCRL ARHGAP1

3.31e-03648731.10.555.10
DomainHMG_box_dom

SOX9 KMT2C TOX2

3.46e-0365873IPR009071
Domain-

ERF IRF6 SMARCC2 FOXC1 FOXP3

3.52e-032188751.10.10.10
DomainPH_dom-like

RAPH1 PHETA1 PTPN21 ASAP1 AFAP1 FGD1 GAB3

3.73e-03426877IPR011993
DomainEPHD

KMT2B KMT2C

4.66e-0322872PS51805
DomainG_patch

ERVK-6 CHERP

5.09e-0323872SM00443
DomainG_patch_dom

ERVK-6 CHERP

5.09e-0323872IPR000467
DomainG_PATCH

ERVK-6 CHERP

5.09e-0323872PS50174
DomainG-patch

ERVK-6 CHERP

5.09e-0323872PF01585
DomainWHTH_DNA-bd_dom

ERF IRF6 SMARCC2 FOXC1 FOXP3

5.47e-03242875IPR011991
Domain-

OCRL SYNJ2

6.48e-03268723.60.10.10
DomainSANT_dom

SMARCC2 RERE

6.48e-0326872IPR017884
DomainExo_endo_phos

OCRL SYNJ2

6.48e-0326872PF03372
DomainEndo/exonuclease/phosphatase

OCRL SYNJ2

6.98e-0327872IPR005135
DomainSANT

SMARCC2 RERE

7.49e-0328872PS51293
DomainSAM

SASH1 PPFIA4 LCP2

8.06e-0388873SM00454
PathwayREACTOME_RHOJ_GTPASE_CYCLE

ARHGAP32 OCRL ARHGAP1

5.26e-0516663MM15605
Pubmed

Human transcription factor protein interaction networks.

SOX9 BCL9L ARHGAP32 KMT2B ERF GATAD2A EP400 RBM33 NUP98 WDR83 GON4L DIDO1 ZMIZ1 PHF21A MED15 KMT2C NFIA PRCC ANKRD17 SMARCC2 RERE FOXC1 INO80E

6.67e-121429972335140242
Pubmed

Interaction network of human early embryonic transcription factors.

BCL9L KMT2B ERF EP400 NUP98 ZMIZ1 PHF21A MED15 KMT2C NFIA SMARCC2 RERE INO80E

1.96e-11351971338297188
Pubmed

A revised nomenclature for transcribed human endogenous retroviral loci.

ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25 ERVK-11

8.85e-099497721542922
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

ARHGAP32 GATAD2A RAPH1 PRR36 RBM33 NUP98 SMC4 PHETA1 OCRL ASAP1 ARHGAP1 FGD1 SMARCC2 PEAK1 PKN3

3.77e-08916971532203420
Pubmed

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

BCL9L ARHGAP32 CHERP RBM33 NUP98 MED15 LSR NFIA

4.30e-0818097835198878
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

BCL9L CHERP EP400 RBM33 PHF21A MED15 NFIA SMARCC2 RERE

6.63e-0826897933640491
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KMT2B EP400 SREBF1 PFAS ABCA7 CHRM4 C2CD2L KMT2C PER2 PCNX4 TP53I13 SLC45A1 MAPKBP1 MBD5 ALOX5 PKN3

6.87e-081105971635748872
Pubmed

Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

ERVK-6 ERVK-7 ERVK-10

8.40e-08497310469592
Pubmed

Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.

ERVK-10 ERVK-18 ERVK-25 ERVK-11

1.69e-071897418664271
Pubmed

Quantitation of HERV-K env gene expression and splicing in human breast cancer.

ERVK-6 ERVK-7 ERVK-18

2.09e-07597312629516
Pubmed

A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development.

SOX9 ERF SREBF1 PHF21A PER2 NFIA

4.37e-0710297619741146
Pubmed

A human MAP kinase interactome.

ARHGAP32 RBM33 NUP98 LCP2 CBLB ASAP1 KMT2C SYNJ2 ANKRD17 MBD5

1.10e-06486971020936779
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

KMT2B EP400 RAPH1 NUP98 DIDO1 ADARB1 NFIA PHACTR4 ANKRD17 SMARCC2 RERE CCDC9

1.72e-06774971215302935
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

ERF GATAD2A EP400 GON4L IRF6 PHF21A MED15 KMT2C SMARCC2

1.81e-0639897935016035
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

KMT2B EP400 RAPH1 SMC4 DIDO1 NCAPH MED15 KMT2C PHACTR4 PEAK1

3.26e-06549971038280479
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

GATAD2A EP400 NUP98 SMC4 RUNX1T1 NCAPH PHF21A NFIA ANKRD17 SMARCC2 FOXC1 FOXP3

4.86e-06857971225609649
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

SOX9 KMT2B GATAD2A EP400 SMARCC2 INO80E

5.41e-0615797630186101
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

BCL9L GATAD2A EP400 NUP98 SMC4 NCAPH KMT2C SMARCC2 CCDC9

6.84e-0646997927634302
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

GATAD2A EP400 RAPH1 RBM33 DIDO1 ASAP1 ARHGAP1 AFAP1 PRCC

7.20e-0647297938943005
Pubmed

A nuclear receptor-like pathway regulating multidrug resistance in fungi.

SREBF1 MED15

7.70e-06297218385733
Pubmed

Comparative proteomic analysis of human leukemic cells with and without inducible expression of leukemogenic AML1-ETO protein.

WDR83 RUNX1T1

7.70e-06297217058450
Pubmed

A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase.

SREBF1 ALOX5

7.70e-06297220173757
Pubmed

Quantitative reduction of the TCR adapter protein SLP-76 unbalances immunity and immune regulation.

LCP2 FOXP3

7.70e-06297225662996
Pubmed

SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.

SOX9 NFIA

7.70e-06297237315400
Pubmed

Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.

ERVK-6 ERVK-18

7.70e-06297211672541
Pubmed

Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.

RERE SLC45A1

7.70e-06297210729226
Pubmed

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

ARHGAP32 KMT2B PPFIA4 SREBF1 RUNX1T1 MED15 DZIP3 SMARCC2 RERE MAPKBP1

7.97e-06608971016713569
Pubmed

A census of human transcription factors: function, expression and evolution.

SOX9 ERF SREBF1 GON4L IRF6 NFIA RERE TOX2 ZNF282 FOXC1 NOBOX FOXP3

8.70e-06908971219274049
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

KMT2B DIDO1 PFAS PER2 SYNJ2

1.12e-051049759205841
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

CHERP EP400 RAPH1 NUP98 DIDO1 PFAS OCRL NCAPH PHF21A PRCC ANKRD17 PKN3

1.15e-05934971233916271
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

CHERP KMT2B GATAD2A EP400 RAPH1 RBM33 PRCC PHACTR4 SMARCC2

1.25e-0550697930890647
Pubmed

Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

RAPH1 CBLB ASAP1 SYNJ2 PHACTR4

1.35e-0510897519531213
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

CHERP KMT2B ERF GATAD2A EP400 NUP98 SREBF1 DIDO1 SLFN5 PHF21A KMT2C NFIA FOXC1 INO80E

1.42e-051294971430804502
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

BCL9L KMT2B EP400 RBM33 ZNF652 SMC4 GON4L DIDO1 C2CD2L MED15 KMT2C LSR AFAP1 ANKRD17 INO80E

1.68e-051497971531527615
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SASH1 EP400 DIDO1 NCAPH PHF21A KMT2C AFAP1 SYNJ2 ANKRD17

1.78e-0552997914621295
Pubmed

In vitro nuclear interactome of the HIV-1 Tat protein.

GATAD2A EP400 NUP98 SMC4 NCAPH SMARCC2

1.86e-0519597619454010
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

EP400 GON4L ASAP1 C2CD2L PER2 DZIP3 RERE MAPKBP1

1.91e-0540797812693553
Pubmed

A-to-I RNA editing enzyme ADAR2 regulates light-induced circadian phase-shift.

ADARB1 PER2

2.31e-05397230287844
Pubmed

Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.

CBLB FOXP3

2.31e-05397220624942
Pubmed

Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

ERVK-6 ERVK-11

2.31e-0539729971820
Pubmed

Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.

PHETA1 OCRL

2.31e-05397220133602
Pubmed

CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.

RUNX1T1 NFIA

2.31e-05397238243303
Pubmed

Uncommon somatic mutations in metastatic NUT midline carcinoma.

DCC KMT2C

2.31e-05397228967088
Pubmed

Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.

ERVK-6 ERVK-18

2.31e-05397210516026
Pubmed

Zbtb20 promotes astrocytogenesis during neocortical development.

SOX9 NFIA

2.31e-05397227000654
Pubmed

DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation.

SOX9 DCC NFIA

2.70e-052197333871356
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

SOX9 ERF SREBF1 DIDO1 PHF21A KMT2C LSR PER2 NFIA TRIM13

2.97e-05709971022988430
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

ARHGAP32 EP400 ZMIZ1 SYNJ2 MBD5

3.30e-0513097512421765
Pubmed

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

KMT2B EP400 DIDO1 NCAPH NFIA

3.82e-0513497525452129
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

KMT2B MYLK SASH1 PPFIA4 ASAP1 SYNJ2 SMARCC2

3.94e-0532997717474147
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

BCL9L RBM33 NUP98 ZMIZ1 MED15 KMT2C PRR14 ANKRD17

4.35e-0545797832344865
Pubmed

Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.

KMT2B KMT2C

4.60e-05497219221051
Pubmed

FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.

NFIA FOXC1

4.60e-05497215684392
Pubmed

ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm.

ADARB1 PER2

4.60e-05497227893733
Pubmed

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

CBLB FOXP3

4.60e-05497223039885
Pubmed

A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.

KMT2B KMT2C

4.60e-05497223129768
Pubmed

ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.

ZNF652 RUNX1T1

4.60e-05497216966434
Pubmed

Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling.

CBLB FOXP3

4.60e-05497238319998
Pubmed

Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.

ERVK-6 ERVK-10

4.60e-0549727983737
Pubmed

Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells.

CBLB FOXP3

4.60e-05497220439537
Pubmed

Inhibitory input directs astrocyte morphogenesis through glial GABABR.

SOX9 NFIA

4.60e-05497237100909
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

BCL9L CHERP GATAD2A EP400 SREBF1 SMC4 DIDO1 PFAS NCAPH PCNX4

4.98e-05754971035906200
Pubmed

Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling.

SOX9 DCC NFIA

5.22e-052697335927240
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ERF EP400 NUP98 PODXL2 OCRL NCAPH ARHGAP1 LSR PHACTR4 PEAK1

6.39e-05777971035844135
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

GATAD2A EP400 GON4L PHF21A SMARCC2

6.54e-0515097528242625
Pubmed

The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.

SOX9 DCC NFIA

7.29e-052997325336744
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

ARHGAP32 GATAD2A RBM33 SMC4 DCC ASAP1 FGD1

7.31e-0536397714691545
Pubmed

A High-Density Map for Navigating the Human Polycomb Complexome.

KMT2B GATAD2A DIDO1 KMT2C PRR14 RERE MBD5 INO80E

7.60e-0549597827705803
Pubmed

T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.

CBLB FOXP3

7.66e-05597223749633
Pubmed

Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.

ERVK-6 ERVK-7

7.66e-05597211401426
Pubmed

The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility.

TOX2 FOXP3

7.66e-05597231732165
Pubmed

The PH domain proteins IPIP27A and B link OCRL1 to receptor recycling in the endocytic pathway.

PHETA1 OCRL

7.66e-05597221233288
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

RAPH1 NUP98 SMC4 DIDO1 NCAPH ANKRD17

8.47e-0525697633397691
Pubmed

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function.

SOX9 SASH1 NFIA

8.93e-053197323408906
Pubmed

An Oct4-centered protein interaction network in embryonic stem cells.

GATAD2A EP400 MED15 KMT2C SMARCC2

1.08e-0416797520362541
Pubmed

Chromosome condensation by a human condensin complex in Xenopus egg extracts.

SMC4 NCAPH

1.15e-04697211136719
Pubmed

An induction gene trap screen in embryonic stem cells: Identification of genes that respond to retinoic acid in vitro.

CHRM4 ANKRD17

1.15e-0469728643689
Pubmed

IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function.

RAPH1 FOXP3

1.15e-04697237598341
Pubmed

Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.

KMT2B KMT2C

1.15e-04697217021013
Pubmed

Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis.

SOX9 NFIA

1.15e-04697228892058
Pubmed

Spatial control of astrogenesis progression by cortical arealization genes.

SOX9 NFIA

1.15e-04697235818636
Pubmed

Direct Binding of Rap1 to Talin1 and to MRL Proteins Promotes Integrin Activation in CD4+ T Cells.

RAPH1 FOXP3

1.15e-04697235197328
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

GATAD2A EP400 SMC4 GON4L DIDO1 NCAPH SMARCC2

1.22e-0439497727248496
Pubmed

Phospho-tyrosine dependent protein-protein interaction network.

KMT2B WDR83 SOCS6 LCP2 CBLB KMT2C INO80E

1.55e-0441097725814554
Pubmed

Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76.

LCP2 GAB3

1.60e-04797212773374
Pubmed

Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

LCP2 CBLB

1.60e-04797210646608
Pubmed

Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation.

CBLB FOXP3

1.60e-04797238761804
Pubmed

YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.

SMC4 NCAPH

1.60e-04797223531880
Pubmed

The novel Nrf2-interacting factor KAP1 regulates susceptibility to oxidative stress by promoting the Nrf2-mediated cytoprotective response.

SMC4 SMARCC2

1.60e-04797221382013
Pubmed

CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.

CBLB ASAP1

1.60e-04797217255943
Pubmed

Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4.

KMT2B KMT2C

1.60e-04797230604749
Pubmed

A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.

KMT2B KMT2C

1.60e-04797219433796
Pubmed

ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.

KMT2B KMT2C

1.60e-04797219556342
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

ARHGAP32 SASH1 OCRL CBLB LSR PHACTR4 PEAK1

1.83e-0442197736976175
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ARHGAP32 RAPH1 ASAP1 ARHGAP1 LSR SYNJ2 PHACTR4 PEAK1

1.88e-0456597825468996
Pubmed

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

ARHGAP32 SASH1 LSR SYNJ2

1.96e-0410297415778465
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ARHGAP32 EP400 NUP98 WDR83 ASAP1 PRR14 XIRP2

2.08e-0443097735044719
Pubmed

The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.

KMT2B KMT2C

2.13e-04897222266653
Pubmed

Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions.

SMC4 NCAPH

2.13e-04897225474630
Pubmed

Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells.

SMC4 NCAPH

2.13e-04897214532007
InteractionSP7 interactions

BCL9L KMT2B EP400 RBM33 WDR83 ZMIZ1 CBLB KMT2C NFIA PRCC SMARCC2 RERE FOXC1

9.42e-103049013int:SP7
InteractionCRK interactions

ARHGAP32 SASH1 WDR83 SOCS6 CBLB PHF21A ASAP1 PRR14 PHACTR4 PEAK1 INO80E

7.84e-073709011int:CRK
InteractionRCOR1 interactions

KMT2B GATAD2A RAPH1 SMC4 SOCS6 NCAPH PHF21A DZIP3 ANKRD17 SMARCC2 PKN3 FOXP3

1.99e-064949012int:RCOR1
InteractionCRX interactions

BCL9L ERF EP400 ZMIZ1 MED15 KMT2C MYO15B NFIA RERE

2.02e-06254909int:CRX
InteractionHCFC1 interactions

KMT2B EP400 DIDO1 NCAPH ADARB1 MED15 KMT2C RERE MBD5

6.47e-06293909int:HCFC1
InteractionTLE3 interactions

SOX9 BCL9L CHERP ZMIZ1 MED15 NFIA DZIP3 SMARCC2 RERE FOXC1

6.89e-063769010int:TLE3
InteractionHDAC1 interactions

KMT2B GATAD2A EP400 RAPH1 NUP98 SREBF1 SMC4 GON4L ZMIZ1 RUNX1T1 NCAPH PHF21A DZIP3 ANKRD17 SMARCC2 RERE FOXP3

7.03e-0611089017int:HDAC1
InteractionEGR2 interactions

BCL9L EP400 PHF21A KMT2C NFIA RERE INO80E

1.16e-05171907int:EGR2
InteractionSNRNP40 interactions

BCL9L CHERP KMT2B GATAD2A EP400 WDR83 GON4L PHF21A NFIA PRCC SMARCC2 FOXC1

2.59e-056379012int:SNRNP40
InteractionAR interactions

BCL9L CHERP EP400 RBM33 SREBF1 DIDO1 SOCS6 ZMIZ1 DCC PHF21A MED15 KMT2C NFIA SMARCC2 RERE

3.11e-059929015int:AR
InteractionDPY30 interactions

KMT2B GATAD2A KMT2C NFIA RERE MBD5 FOXP3

3.61e-05204907int:DPY30
InteractionLCK interactions

ARHGAP32 OCRL SOCS6 LCP2 CBLB LSR PHACTR4 FGD1 PEAK1 PKN3

4.12e-054639010int:LCK
InteractionSIN3A interactions

GATAD2A SREBF1 SMC4 GON4L RUNX1T1 ADARB1 PER2 DZIP3 SMARCC2

5.04e-05380909int:SIN3A
InteractionGRB2 interactions

ARHGAP32 RBM33 PHETA1 OCRL LCP2 CBLB CHRM4 ASAP1 SYNJ2 PHACTR4 GAB3 PEAK1 ALOX5

5.81e-058069013int:GRB2
InteractionACTC1 interactions

CHERP KMT2B MYLK GATAD2A EP400 RAPH1 RBM33 ADARB1 AFAP1 PRCC PHACTR4 SMARCC2

5.93e-056949012int:ACTC1
InteractionKDM1A interactions

KMT2B EP400 RAPH1 WDR83 SOCS6 ZMIZ1 ADARB1 PHF21A DZIP3 ANKRD17 SMARCC2 RERE FOXC1 FOXP3

7.02e-059419014int:KDM1A
InteractionNFIX interactions

SOX9 KMT2B EP400 KMT2C NFIA SMARCC2 FOXC1

7.09e-05227907int:NFIX
InteractionSOX9 interactions

SOX9 EP400 KMT2C NFIA SMARCC2

7.40e-0597905int:SOX9
InteractionTOP3B interactions

KMT2B EP400 RBM33 SREBF1 PFAS ABCA7 CHRM4 C2CD2L KMT2C PER2 PCNX4 TP53I13 ANKRD17 SLC45A1 MAPKBP1 MBD5 ALOX5 PKN3

7.47e-0514709018int:TOP3B
InteractionPIK3R1 interactions

ARHGAP32 MAP6 SOCS6 LCP2 CBLB ARHGAP1 GAB3 SMARCC2 ALOX5

9.36e-05412909int:PIK3R1
InteractionCLOCK interactions

NUP98 PHF21A PER2 DZIP3 PKN3

9.40e-05102905int:CLOCK
InteractionHMG20A interactions

GATAD2A GON4L PHF21A NFIA DZIP3 PKN3 FOXC1

1.11e-04244907int:HMG20A
InteractionPCDHB11 interactions

ERF C2CD2L TP53I13 PEAK1

1.14e-0456904int:PCDHB11
InteractionDTX2 interactions

BCL9L ARHGAP32 CHERP RBM33 NUP98 MED15 LSR NFIA

1.15e-04330908int:DTX2
InteractionBMAL1 interactions

NUP98 PHF21A PER2 DZIP3 PKN3

1.40e-04111905int:BMAL1
InteractionRBPJ interactions

KMT2B GATAD2A ZMIZ1 RUNX1T1 PHF21A NFIA SMARCC2

1.43e-04254907int:RBPJ
InteractionBCL7C interactions

SOX9 NFIA PHACTR4 SMARCC2 FOXP3

1.66e-04115905int:BCL7C
InteractionLHX2 interactions

BCL9L ARHGAP32 EP400 KMT2C NFIA SMARCC2

1.71e-04183906int:LHX2
InteractionNCK2 interactions

ARHGAP32 RAPH1 PHETA1 LCP2 CBLB ASAP1 PEAK1

1.73e-04262907int:NCK2
InteractionMEN1 interactions

CHERP KMT2B GATAD2A EP400 NUP98 SMC4 DIDO1 CBLB KMT2C PRCC ANKRD17 SMARCC2 RERE FOXC1

1.80e-0410299014int:MEN1
InteractionYY1 interactions

KMT2B EP400 SREBF1 GON4L DIDO1 NFIA DZIP3 INO80E FOXP3

1.94e-04454909int:YY1
InteractionHNF4A interactions

KMT2B EP400 SREBF1 KMT2C NFIA SMARCC2 FOXC1

2.32e-04275907int:HNF4A
InteractionINO80D interactions

SREBF1 MED15 INO80E

2.33e-0427903int:INO80D
InteractionFOXL1 interactions

NUP98 SMC4 NCAPH KMT2C NFIA FOXC1

2.48e-04196906int:FOXL1
InteractionELF1 interactions

KMT2B EP400 NFIA FOXC1 FOXP3

2.54e-04126905int:ELF1
InteractionFEV interactions

KMT2B EP400 PHF21A KMT2C NFIA FOXC1

2.99e-04203906int:FEV
InteractionZBTB7A interactions

SOX9 GATAD2A SREBF1 SMC4 SMARCC2

3.04e-04131905int:ZBTB7A
InteractionTLX3 interactions

BCL9L WDR83 KMT2C NFIA RERE TOX2 FOXC1

3.27e-04291907int:TLX3
InteractionTBC1D4 interactions

EP400 SMC4 ZMIZ1 PHF21A SLC45A1

3.49e-04135905int:TBC1D4
InteractionMTNR1B interactions

SREBF1 ARHGAP1 KMT2C PCNX4 PEAK1

3.49e-04135905int:MTNR1B
InteractionFYB1 interactions

LCP2 CBLB FOXP3

3.54e-0431903int:FYB1
InteractionPHF20L1 interactions

KMT2B GATAD2A KMT2C RERE

3.55e-0475904int:PHF20L1
InteractionEPHB2 interactions

ARHGAP32 ERF RAPH1 LSR PHACTR4 PEAK1

4.16e-04216906int:EPHB2
InteractionRAC3 interactions

ARHGAP32 PODXL2 OCRL ASAP1 ARHGAP1 LSR SYNJ2 PHACTR4 PEAK1 TRIM13

4.37e-046199010int:RAC3
InteractionHDAC2 interactions

GATAD2A EP400 SMC4 RUNX1T1 NCAPH ADARB1 PHF21A C2CD2L ANKRD17 SMARCC2 RERE FOXP3

4.56e-048659012int:HDAC2
InteractionH2BC3 interactions

GATAD2A EP400 GON4L DIDO1 NCAPH ADARB1 KMT2C SMARCC2

4.65e-04406908int:H2BC3
InteractionNUP43 interactions

BCL9L KMT2B ERF GATAD2A EP400 NUP98 GON4L PHF21A NFIA RERE

4.71e-046259010int:NUP43
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

EP400 GON4L SMARCC2 RERE

3.90e-0553654532
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

RAPH1 PHETA1 ASAP1 AFAP1 FGD1 GAB3

9.60e-05206656682
GeneFamilyPHD finger proteins

KMT2B DIDO1 PHF21A KMT2C

3.08e-049065488
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

GATAD2A RERE

1.30e-031565282
GeneFamilyAtaxins|Trinucleotide repeat containing

EP400 MED15

3.62e-0325652775
CoexpressionGSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP

BCL9L CDHR1 ZNF652 PHF21A GAB3 RERE PEAK1

5.93e-06200907M5046
CoexpressionGSE11924_TH2_VS_TH17_CD4_TCELL_DN

ZMIZ1 ABCA7 PHF21A ARHGAP1 TP53I13 SMARCC2 TRIM13

5.93e-06200907M3165
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL

ARHGAP32 SGSM1 GATAD2A SASH1 GLB1L PEAK1

5.49e-05193906M6813
CoexpressionZHONG_PFC_C3_ASTROCYTE

MAP6 RBM33 PODXL2 RUNX1T1 AFAP1 PHACTR4 RERE SLC45A1

5.88e-05389908M39102
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL

ARHGAP32 SGSM1 GATAD2A SASH1 GLB1L PEAK1

5.99e-05196906MM667
CoexpressionGSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN

CDHR1 ABCA7 LSR DZIP3 TP53I13 PEAK1

6.16e-05197906M7921
CoexpressionTHAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN

RBM33 SREBF1 GON4L DIDO1 ZMIZ1 CBLB ARHGAP1 PRR14 PHACTR4 TP53I13 SMARCC2 ALOX5

6.16e-059059012M40865
CoexpressionTHAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN

RBM33 SREBF1 DIDO1 ZMIZ1 CBLB ARHGAP1 PHACTR4 TP53I13 SMARCC2 ALOX5

6.42e-056349010M40866
CoexpressionGSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP

GATAD2A ASAP1 MED15 ARHGAP1 PRCC RERE

6.51e-05199906M9964
CoexpressionGSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN

MYLK SASH1 RBM33 IRF6 NFIA PHACTR4

6.69e-05200906M7518
ToppCellfacs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP6 SMC4 LCP2 ANGPTL2 TOX2 FOXP3

1.41e-06173906f2eeff86e7dc7f4e3c36f775777d56685d7096cf
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

1.96e-06183906612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

1.96e-06183906848fc6dd129150897ee339343e83c645b6e779eb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

1.96e-06183906eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

1.96e-061839067c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

2.08e-061859069197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

2.08e-06185906ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 SLC45A1 FOXC1

2.08e-06185906b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SMC4 SLFN5 LCP2 CBLB DZIP3 GAB3

2.66e-06193906544de0988510cc57744710d7cafe07aa27a0b99d
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IRF6 C2CD2L LSR PRR14 FOXC1

1.58e-051559058e239470799426ea474a36f57e1b7e0d9365ca5f
ToppCellCV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster

PPFIA4 PFAS F12 SYNJ2 ZNF282

2.75e-0517490526544cc5f51cb4dc1251e62d9f80b6c956194d38
ToppCellfacs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP6 LCP2 ANGPTL2 TOX2 FOXP3

2.75e-05174905096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SLC45A1 FOXC1

2.99e-051779054d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP6 LCP2 ANGPTL2 TOX2 FOXP3

3.07e-05178905888add8935ef3aef9b6693c5698e9d1842e66337
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP6 LCP2 ANGPTL2 TOX2 FOXP3

3.07e-0517890543eda32af2e5e28a92421612d0a4c21e5427a772
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SLC45A1 FOXC1

3.07e-05178905edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB XIRP2 SLC45A1

3.32e-051819055bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB XIRP2 SLC45A1

3.32e-051819058e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCellCOVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type

MAP6 PPFIA4 CBLB SLC45A1 FOXC1

3.50e-05183905fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 FOXC1

3.50e-051839053c516fe5083f02bad1f464ed284010b4131a833c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 FOXC1

3.50e-051839059c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SREBF1 SMC4 IRF6 LSR FOXC1

3.50e-05183905b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMC4 LCP2 ANGPTL2 TOX2 FOXP3

3.59e-051849058c23945bafe8926f25836bc208115edd5214a2b0
ToppCellControl-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

GON4L NCAPH MED15 MYO15B PRCC

3.59e-05184905ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SYNJ2 FOXC1

3.59e-051849057294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

RUNX1T1 SYNJ2 TOX2 PKN3 FOXC1

3.69e-05185905a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCellE16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass

MYLK RUNX1T1 ADARB1 NFIA PEAK1

3.98e-051889053f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SOX9 MAP6 PTPN21 C17orf107 FOXC1

3.98e-05188905c9270517e6940e9793586f67f02431210552f278
ToppCellT_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

SLFN5 LCP2 CBLB ADARB1 DZIP3

4.08e-05189905e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

MYLK RUNX1T1 AFAP1 NFIA PEAK1

4.08e-051899050c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

MYLK RUNX1T1 CBLB ADARB1 PEAK1

4.19e-051909051196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor

RUNX1T1 SYNJ2 TOX2 PKN3 FOXC1

4.19e-05190905f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYLK DCC RUNX1T1 ADARB1 AFAP1

4.29e-05191905b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NUP98 CBLB ASAP1 SYNJ2 TOX2

4.29e-0519190508720998aa55131d7377c4c67c4c935865bd7d79
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SOX9 ERF IRF6 LSR PER2

4.29e-051919054180521a8c5e0ad629cacdd22dc6a94e94b28816
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYLK DCC RUNX1T1 ADARB1 AFAP1

4.40e-051929056f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell10x5'v1-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SGSM1 CDHR1 SLFN5 LCP2 TOX2

4.40e-0519290563e815664b228575886396387d2738cd73855759
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

GATAD2A ASAP1 SYNJ2 PEAK1 ALOX5

4.40e-051929058b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYLK DCC RUNX1T1 ADARB1 AFAP1

4.40e-051929053d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SGSM1 CDHR1 SLFN5 LCP2 TOX2

4.40e-05192905095151a4f878944835945f698aa0e3b540ffc8c3
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NUP98 ASAP1 KMT2C ANKRD17 RERE

4.51e-05193905779276e775cb2492e8dd36436295a536084a6415
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYLK DCC RUNX1T1 ADARB1 AFAP1

4.62e-051949056e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYLK DCC RUNX1T1 ADARB1 AFAP1

4.62e-0519490589b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

MYLK RUNX1T1 NFIA RERE MBD5

4.74e-051959050e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellBLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SMC4 SLFN5 NCAPH TOX2 FOXP3

4.74e-0519590545515d5da8a8c8242eb70a1bea24fe44eca5407b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RUNX1T1 ADARB1 ASAP1 SYNJ2 PKN3

4.85e-051969058ad8efb631164b46f0c082572270188e5ead20bf
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CDHR1 SMC4 IRF6 LSR FOXC1

4.85e-051969057d5eaed189aa6116f3799be010139fb675ec65e0
ToppCellfacs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX9 MAP6 ZMIZ1 ANGPTL2 FOXC1

4.85e-05196905c936014125b2ed5f796221b74acb77b8f8359875
ToppCellPND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYLK ADARB1 ANGPTL2 NFIA PEAK1

4.85e-05196905ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RUNX1T1 ADARB1 ASAP1 SYNJ2 PKN3

4.85e-051969059606ea7e42f707e69ea891b3521037613b9675f5
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RUNX1T1 ASAP1 SYNJ2 TOX2 PKN3

5.09e-05198905b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCellFibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

SASH1 RUNX1T1 ANGPTL2 NFIA FOXC1

5.22e-0519990540de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCellTransverse-T_cell-gd_T|Transverse / Region, Cell class and subclass

SMC4 LCP2 CBLB ADARB1 DZIP3

5.22e-0519990592554fddd887fe6c1c943ed704d4a02c999ba830
ToppCellTransverse-(1)_T_cell-(17)_gd_T|Transverse / shred on region, Cell_type, and subtype

SMC4 LCP2 CBLB ADARB1 DZIP3

5.22e-05199905a3a29ed65881f1dcf09b2fec8788161ea3adef48
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 KMT2C NFIA RERE MBD5

5.22e-0519990594b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SOX9 CLCA4 SREBF1 IRF6 FOXC1

5.22e-05199905c88a28a73f54dc571f2ff1e4b55073f83cbead2c
ToppCellfacs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX9 SASH1 ANGPTL2 NFIA FOXC1

5.22e-0519990567f78c070c56e44fba36542041bf7fa1c291807c
ToppCellfacs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX9 SASH1 ANGPTL2 NFIA FOXC1

5.22e-051999051ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCellControl-Control-Lymphocyte-T/NK-NK_CD56bright|Control / Disease, condition lineage and cell class

CDHR1 SLFN5 CBLB DZIP3 FOXC1

5.34e-05200905d843fe0781c7699afead4429c526441c6fdb8cba
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type.

CDHR1 DCC CBLB AFAP1 RERE

5.34e-05200905332905a686356cd1e024d40679be98e9d8b1b5e8
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type.

SOX9 SMC4 NCAPH ANGPTL2 PKN3

5.34e-052009050bba93f1271dac704dddcdea8cb0f84a7ac6f42a
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type.

SOX9 SMC4 NCAPH ANGPTL2 PKN3

5.34e-05200905c9479452ab8c51139522383f745f02171ebbd7e2
ToppCell(17)_gd_T|World / shred on Cell_type and subtype

SMC4 SLFN5 LCP2 CBLB DZIP3

5.47e-052019057fcfe48758acf07cb3dda939ce589ae1518e41c9
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

IRF6 SLFN5 LSR PKN3

1.49e-0413290406e7337de35bd7120655a22b6020604ad004c4e1
ToppCellHippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32

IRF6 SLFN5 LSR PKN3

1.81e-0413990434398a6f21a1e670497655a7bb7f3cde9e117560
ToppCellHippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

IRF6 SLFN5 LSR PKN3

1.81e-04139904450c4152c9fe4ec503271bb3cf93739918c59509
ToppCellfacs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPFIA4 SLFN5 LCP2 ALOX5

2.37e-0414990423a1b95c12f2e3708dc003e13fab423e89821f11
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

IRF6 SLFN5 LSR PKN3

2.37e-04149904d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCellfacs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPFIA4 SLFN5 LCP2 ALOX5

2.37e-04149904c53a3226adc8fd0eaaa842b6a96442287580cbe0
ToppCellfacs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPFIA4 SLFN5 LCP2 ALOX5

2.37e-04149904bb18a18b891af85849b9658d774053f839c9a8e1
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SLFN5 CBLB DZIP3 TOX2

2.55e-04152904405d19b290232bb3e564d61c0cff0cfdd247bdff
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SLFN5 CBLB DZIP3 TOX2

2.55e-0415290406fa7d8acc8f56de00af9bee17884595b300410e
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SLFN5 CBLB DZIP3 TOX2

2.62e-04153904b101cb1bce5db785dab46b6c4f7be9c3efe48b0e
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SLFN5 CBLB DZIP3 TOX2

2.62e-04153904487388082bb596809ba1caf9197626b6814792ab
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells)

AFAP1 DZIP3 TOX2 ZNF282

2.75e-0415590498d8432739965dd1ab77c899cb6321f7f05eaa46
ToppCellCOVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class

SLFN5 CBLB DZIP3 TOX2

2.82e-0415690483f25683e0f55472b56f915ee176fc05efc33a31
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RAPH1 CDHR1 ZNF652 OCRL

2.96e-0415890474aa4f75307575ac3b2b1aa9f727753692f88742
ToppCellfacs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHETA1 DZIP3 MBD5 TOX2

3.10e-04160904b3f7ef7e682b48a83ca425f5c439336e96168300
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PRR36 PODXL2 DCC NFIA

3.18e-04161904bd520c9a1927d5d5355b4421e6b90b58bfb76a42
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

C2CD2L XIRP2 GAB3 SLC45A1

3.41e-04164904d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

CDHR1 CBLB TOX2 FOXC1

3.57e-04166904ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LCP2 CBLB GAB3 FOXC1

3.65e-041679049c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ERICH3 MYLK LCN12 PRCC

3.65e-04167904f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

AFAP1 DZIP3 TOX2 ZNF282

3.65e-041679046c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1
ToppCelldroplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADARB1 PER2 PHACTR4 MBD5

3.73e-041689042201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCellPND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGAP32 PPFIA4 GLB1L MBD5

3.73e-0416890427cdf5cfa1d906868cfd60fdfab3cd51f3b3602f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SLC45A1

3.73e-04168904e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCellMild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ARHGAP32 IRF6 ADARB1 RERE

3.82e-04169904c3a6179a64589a370108fea809b157839347759c
ToppCellCOVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class

CDHR1 SLFN5 CBLB DZIP3

3.90e-04170904caa6a534c1e9639caced9a51680f5c905f061bcc
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SMC4 LCP2 CHRM4 FOXP3

3.99e-041719044c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SMC4 LCP2 CHRM4 FOXP3

3.99e-04171904c5c1d23b4040a78991512bfcbe046c51f202d2cf
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP6 PPFIA4 CBLB SLC45A1

4.08e-04172904381ae1c3c07d0a424f43455ec571653b192a946a
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GON4L LCP2 CCDC9 ALOX5

4.17e-04173904c31076c725f4cd912c56903592a2d9356ae59f54
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GON4L LCP2 CCDC9 ALOX5

4.17e-04173904a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCelldroplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMC4 LCP2 ANGPTL2 FOXP3

4.26e-04174904919fc124affc69acfd8f575f2c372674f3d2625e
ToppCellCOVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAP6 PPFIA4 SLC45A1 FOXC1

4.35e-04175904a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYO15B TOX2 CCDC9 ALOX5

4.35e-0417590487e557f7508c88b2087db5d57e77d5e2c92ca083
ToppCellfacs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PFAS NFIA PKN3 FOXC1

4.64e-041789045cc182e6faa7ba5b88378d2c953be29bbbb95a7e
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells)

GATAD2A OCRL KMT2C SLC45A1

4.64e-04178904536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells)

NCAPH F12 TOX2 FOXP3

4.64e-041789048b939659f713eea50a1a6e28b571f680ca0b4c12
DrugFolic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A

SASH1 ZNF652 PTPN21 ASAP1 C2CD2L SYNJ2 PHACTR4 CCDC9

1.36e-061979287201_DN
Drug5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA

SASH1 EP400 SREBF1 CBLB ARHGAP1 SYNJ2 PCNX4 FOXC1

1.42e-06198928961_DN
DrugMuramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A

KMT2B MYLK ZNF652 PTPN21 ADARB1 SYNJ2 RERE

1.22e-051909274582_DN
DrugSulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A

PRR36 GLB1L ZNF652 GON4L AFAP1 SYNJ2 PHACTR4

1.22e-051909273373_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

SOX9 NUP98 PODXL2 MED15 SYNJ2 MAPKBP1 CCDC9

1.35e-051939271667_DN
DrugDizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A

KMT2B GATAD2A IRF6 PTPN21 C2CD2L MED15 ZNF282

1.35e-051939276223_UP
DrugAdiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; MCF7; HT_HG-U133A

DIDO1 IRF6 PODXL2 PTPN21 MED15 AFAP1 ZNF282

1.44e-051959277037_UP
DrugDipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A

GATAD2A EP400 SREBF1 DIDO1 F12 ARHGAP1 PHACTR4

1.44e-051959272017_DN
DrugFlupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A

GATAD2A EP400 DIDO1 DZIP3 SMARCC2 MAPKBP1 ZNF282

1.44e-051959275307_DN
Drug2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A

KMT2B SMC4 PTPN21 ABCA7 C2CD2L SYNJ2 SMARCC2

1.49e-051969275569_DN
DrugYohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A

GLB1L SMC4 GON4L PODXL2 RUNX1T1 ADARB1 SYNJ2

1.49e-051969272755_DN
Drugnordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A

SMC4 PODXL2 ABCA7 C2CD2L SYNJ2 FGD1 ZNF282

1.59e-051989275583_DN
DrugSaquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A

SOCS6 RUNX1T1 ADARB1 ANGPTL2 DZIP3 FGD1 RERE

1.59e-051989276127_UP
DrugDioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A

SOX9 KMT2B NUP98 GON4L PTPN21 DZIP3 SMARCC2

1.59e-051989275699_DN
DrugTriamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ARHGAP32 SOCS6 PTPN21 MED15 PHACTR4 DZIP3 SMARCC2

1.64e-051999277192_DN
DrugHemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A

MYLK PRR36 RUNX1T1 ADARB1 AFAP1 ANGPTL2 RERE

1.64e-051999273216_UP
DrugDiltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A

ASAP1 MED15 ARHGAP1 SYNJ2 MAPKBP1 ZNF282 FOXC1

1.64e-051999275309_DN
Drug6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine

ERICH3 RAPH1 PRR36 ZMIZ1 RERE

6.48e-05104925ctd:C000595015
DrugSulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A

SOX9 KMT2B PTPN21 ABCA7 ANGPTL2 FGD1

1.19e-041899264998_UP
DrugTerfenadine [50679-08-8]; Down 200; 8.4uM; HL60; HG-U133A

GATAD2A NUP98 DIDO1 PFAS ASAP1 RERE

1.19e-041899261381_DN
DrugSparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A

SOX9 ZNF652 ADARB1 ARHGAP1 PHACTR4 FGD1

1.19e-041899262790_DN
DrugTrifluridine [70-00-8]; Down 200; 13.6uM; HL60; HT_HG-U133A

NUP98 DIDO1 F12 C2CD2L PER2 MAPKBP1

1.26e-041919266136_DN
DrugTrichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A

ZNF652 SMC4 GON4L PTPN21 SYNJ2 DZIP3

1.34e-041939265989_DN
DrugMethazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A

KMT2B ZNF652 DIDO1 IRF6 PODXL2 FOXP3

1.34e-041939263474_UP
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A

NUP98 GON4L ARHGAP1 SYNJ2 MAPKBP1 CCDC9

1.38e-041949262293_DN
DrugAcetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A

KMT2B PRR36 GON4L C2CD2L SYNJ2 RERE

1.38e-041949265384_DN
DrugCimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A

EP400 DIDO1 NCAPH LSR RERE MAPKBP1

1.38e-041949261884_DN
DrugCyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A

PRR36 PODXL2 FGD1 RERE ZNF282 CCDC9

1.41e-041959264813_UP
DrugZimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A

ZNF652 DIDO1 PTPN21 C2CD2L FGD1 ZNF282

1.45e-041969261512_DN
Drugaspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A

ARHGAP32 ZNF652 IRF6 PTPN21 C2CD2L PHACTR4

1.45e-041969261629_DN
DrugPHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A

PRR36 GLB1L ZNF652 SMC4 GON4L IRF6

1.45e-041969263857_DN
DrugXylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A

PPFIA4 GLB1L RUNX1T1 ANGPTL2 PEAK1 ALOX5

1.45e-041969264066_UP
DrugSulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A

ERF SMC4 RUNX1T1 PHACTR4 SMARCC2 MAPKBP1

1.45e-041969261967_DN
DrugCondelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A

KMT2B EP400 SMC4 PTPN21 LSR CCDC9

1.45e-041969266357_DN
DrugPilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

KMT2B ERF IRF6 C2CD2L SYNJ2 MAPKBP1

1.50e-041979265341_DN
DrugChlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A

PTPN21 ADARB1 PER2 SYNJ2 RERE CCDC9

1.50e-041979267472_UP
Drug2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A

SOX9 SASH1 IRF6 PTPN21 SYNJ2 PHACTR4

1.50e-041979261634_DN
DrugDiethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A

ARHGAP32 EP400 SREBF1 ARHGAP1 RERE CCDC9

1.50e-041979264547_DN
Drugrofecoxib; Up 200; 10uM; MCF7; HG-U133A

SASH1 GLB1L NUP98 GON4L ADARB1 ASAP1

1.50e-04197926205_UP
DrugPheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A

RUNX1T1 ABCA7 AFAP1 ANGPTL2 SYNJ2 FGD1

1.50e-041979264130_UP
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARHGAP32 NUP98 PODXL2 OCRL C2CD2L MAPKBP1

1.50e-041979266935_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

PRR36 IRF6 PODXL2 SOCS6 PTPN21 ARHGAP1

1.50e-041979261473_DN
DrugConvolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

KMT2B SASH1 DIDO1 PTPN21 SYNJ2 SMARCC2

1.50e-041979267230_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

PRR36 NUP98 SREBF1 DIDO1 PCNX4 CCDC9

1.54e-041989261669_DN
Drug5155877; Down 200; 10uM; PC3; HT_HG-U133A

SOX9 KMT2B PTPN21 ABCA7 AFAP1 CCDC9

1.54e-041989266544_DN
Drug5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA

SOX9 KMT2B SASH1 DIDO1 IRF6 ARHGAP1

1.54e-04198926950_DN
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A

SMC4 C2CD2L SYNJ2 DZIP3 FGD1 RERE

1.54e-041989263847_DN
DrugSulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A

SOX9 EP400 ARHGAP1 PHACTR4 RERE ZNF282

1.54e-041989263449_DN
DrugIsometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A

PTPN21 ABCA7 C2CD2L ARHGAP1 AFAP1 DZIP3

1.54e-041989266524_DN
DrugSulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A

SASH1 SMC4 C2CD2L MED15 AFAP1 MAPKBP1

1.54e-041989267200_DN
DrugIsocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A

ZNF652 NUP98 PODXL2 PTPN21 SYNJ2 CCDC9

1.54e-041989263424_DN
DrugCP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A

PTPN21 ADARB1 ABCA7 CHRM4 ARHGAP1 CCDC9

1.54e-041989267549_UP
DrugButirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A

MYLK SASH1 PTPN21 ADARB1 C2CD2L AFAP1

1.54e-041989266080_DN
DrugEstropipate [7280-37-7]; Up 200; 9.2uM; PC3; HT_HG-U133A

GLB1L ZNF652 MED15 ARHGAP1 AFAP1 ANGPTL2

1.54e-041989264472_UP
DrugBacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A

KMT2B GON4L ADARB1 PRR14 SYNJ2 ZNF282

1.54e-041989264592_DN
DrugCytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A

NUP98 GON4L OCRL SYNJ2 PRCC ZNF282

1.54e-041989261766_DN
DrugAcetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A

KMT2B GATAD2A PODXL2 PTPN21 PHACTR4 DZIP3

1.58e-041999261808_UP
DrugGuanethidine sulfate [60-02-6]; Down 200; 13.4uM; HL60; HG-U133A

ZNF652 RUNX1T1 NCAPH ASAP1 PRCC PHACTR4

1.58e-041999261554_DN
DrugCimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A

GON4L DIDO1 ASAP1 ANGPTL2 PER2 ANKRD17

1.58e-041999261964_UP
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

GLB1L GON4L IRF6 PTPN21 SYNJ2 MAPKBP1

1.58e-041999265458_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A

ARHGAP32 EP400 NUP98 OCRL AFAP1 PHACTR4

1.58e-041999266324_DN
DrugSB 202190; Up 200; 1uM; PC3; HT_HG-U133A

MYLK DIDO1 SOCS6 ABCA7 SYNJ2 ZNF282

1.58e-041999267058_UP
DrugCID365768

RUNX1T1 ALOX5

1.60e-045922CID000365768
DrugAC1Q6DXY

ERVK-6 ERF PKN3

2.16e-0429923CID000003719
DiseaseIntellectual Disability

SOX9 GON4L ZMIZ1 DCC PHF21A KMT2C NFIA SMARCC2

6.83e-05447908C3714756
Diseasemigraine disorder, type 1 diabetes mellitus

RERE SLC45A1

9.15e-055902MONDO_0005147, MONDO_0005277
Diseaseeosinophil count

CHERP ZNF652 SREBF1 SMC4 PHETA1 LCP2 CBLB NCAPH RERE PEAK1 MBD5 TOX2 ZNF282 CCDC9

1.60e-0414889014EFO_0004842
Diseaseschizophrenia, type 2 diabetes mellitus

GATAD2A RUNX1T1 ARHGAP1

3.10e-0443903MONDO_0005090, MONDO_0005148
DiseaseHeadache, glucose measurement

SGSM1 GATAD2A

3.27e-049902EFO_0004468, HP_0002315
DiseaseSchizophrenia

ARHGAP32 MAP6 SREBF1 PTPN21 DCC ADARB1 CHRM4 MED15 ARHGAP1 ERVK-8

3.61e-048839010C0036341
Diseaseeosinophil percentage of leukocytes

KMT2B ZNF652 LCP2 NCAPH ABCA7 RERE MBD5 TOX2 ZNF282

4.58e-04746909EFO_0007991
Diseasemeningitis

RAPH1 RERE

4.97e-0411902MONDO_0021108
Diseasewhite matter microstructure measurement

SOX9 CHERP KMT2B SASH1 RAPH1 DCC

1.26e-03390906EFO_0005674
DiseaseCraniofacial Abnormalities

SOX9 ERF IRF6 FGD1

1.35e-03156904C0376634
Diseaselevel of Phosphatidylcholine (18:1_20:4) in blood serum

GATAD2A DCC

1.86e-0321902OBA_2045104
Diseaseautoimmune disease

SASH1 ZMIZ1 CBLB DZIP3

1.97e-03173904EFO_0005140
DiseaseLeukemia, Myelocytic, Acute

NUP98 RUNX1T1 CBLB KMT2C

1.97e-03173904C0023467
Diseasecup-to-disc ratio measurement

SASH1 PHETA1 CBLB ASAP1 AFAP1 RERE

2.06e-03430906EFO_0006939
Diseasefeeling nervous measurement

NFIA MBD5 INO80E

2.42e-0387903EFO_0009597
Diseasestomach carcinoma (is_marker_for)

CBLB KMT2C

2.43e-0324902DOID:5517 (is_marker_for)
Diseasehypertrophic cardiomyopathy

PHF21A ARHGAP1 KMT2C

2.83e-0392903EFO_0000538

Protein segments in the cluster

PeptideGeneStartEntry
PAMPAPPLQPRALNP

CHRM4

321

P08173
QPQRPDKCPLPPMAP

ERF

341

P50548
NINSYMMPIPPPLPP

ERICH3

226

Q5RHP9
QKQKLQMPPQPPPPQ

EP400

2821

Q96L91
QPTQPPPKPKTMGSP

CDHR1

821

Q96JP9
PPVCPAPPMNGLLQL

CDCP2

401

Q5VXM1
APPQMPLPEIPQPWL

AFAP1

61

Q8N556
QNLKVLPPPLPTMPT

ANGPTL2

246

Q9UKU9
ALPMVVPPQEPDKPP

ANKRD17

751

O75179
PQPTKQSPLEPPMLD

ABCA7

141

Q8IZY2
KVHNPFLPTPMLPPP

NFIA

426

Q12857
HLSVPPPPLMPMSQP

RBM33

641

Q96EV2
PPPTPPAMESQPLKP

RAPH1

871

Q70E73
MAPPPPSPQLLLLAA

TP53I13

1

Q8NBR0
LPAVPMEPKPDPFPQ

NOBOX

391

O60393
LEIPPPKPPAPEMNF

GATAD2A

361

Q86YP4
NLPSPLPKMNLVEPP

PODXL2

141

Q9NZ53
ANPLLPPPMSAIEPK

DCC

1346

P43146
TPLQMALNGKPAPPP

NUP98

916

P52948
PAPKTPPKAAMPPQI

MYLK

1226

Q15746
PASLPPTPPPMACQK

KMT2C

3901

Q8NEZ4
PPQPQLTPPNTPKLV

MAFIP

41

Q8WZ33
PSVPVPPKNQSPMVP

MAP6

531

Q96JE9
LNPMPPSQLQLPTLP

FOXP3

61

Q9BZS1
KTQSRLTPPTMPPPP

RUNX1T1

46

Q06455
TPTPLPLPPPMQSFQ

LCN12

21

Q6JVE5
DIMSNTPPPRPPKPS

GAB3

301

Q8WWW8
LQPPPAPPKKIMPEA

PPFIA4

1156

O75335
MVRKQDKPLPAPPPP

CBLB

536

Q13191
VQPPPFPAPLAPVMA

PER2

891

O15055
APLMLPALNTLPPPK

PCNX4

791

Q63HM2
NASQPTPPPLPKKMI

PEAK1

1146

Q9H792
KNDMAVPTPPPPPVP

MED15

596

Q96RN5
IAPAPPPMLAAPQLI

PHF21A

246

Q96BD5
PLQPGLPSPAMIPKD

HERVK_113

101

P63132
QPPPSPQQMPPLEKA

KMT2B

761

Q9UMN6
PPFPPPSGKNPVMIL

ADARB1

226

P78563
PPPPPPKNVARMLAL

ARHGAP32

1031

A7KAX9
HMVPAKQPPIPPPKP

PHACTR4

251

Q8IZ21
PLQPGLPSPAMIPKD

ERVK-7

101

P63135
PLQPGLPSPAMIPKD

ERVK-6

101

Q9BXR3
LPPPPPSPEILMQQF

DZIP3

951

Q86Y13
VGTTLTPLPPPKMPP

INO80E

196

Q8NBZ0
LPKPQPYVMPPPPQL

PTPN21

331

Q16825
PAMPAMVVPPQPPLP

MYO15B

851

Q96JP2
PLQPGLPSPAMIPKD

ERVK-18

101

Q9QC07
KPPMMPQAQPAIPRP

C2CD2L

271

O14523
LEPAATMPPLPQPPL

CHERP

76

Q8IWX8
PYTPQPQPKDMVKPP

FOXC1

66

Q12948
PKETPMQPPEIPAPA

CCDC9

391

Q9Y3X0
PPEPKMQGMLPAPKP

C17orf107

56

Q6ZR85
QEVPLGPLPPPSPKM

GLB1L

356

Q6UWU2
MGPPPPPKPKQTRDS

GON4L

446

Q3T8J9
MVPLPSANPPGPLKS

BCL9L

961

Q86UU0
PQVMKPGPRPLLELP

DIDO1

2016

Q9BTC0
PPKPQMKDLPPKPQL

ASAP1

981

Q9ULH1
QPPPPEKTPNPMECT

MAPKBP1

1386

O60336
MPPAVVPLPSNLPLP

MBD5

396

Q9P267
AMKSPSLPLPPSPPV

SLC45A1

336

Q9Y2W3
LSPAKTPPPPAMIPM

LSR

331

Q86X29
EMTPPPKPPRLYLPQ

PKN3

506

Q6P5Z2
PMQPTPSMQLPPALP

IRF6

451

O14896
LHVPLMPAQPAPPKP

F12

311

P00748
MPAQPAPPKPQPTTR

F12

316

P00748
MALPQPQPQSLPLPP

PHETA1

136

Q8N4B1
KGPALLPPPPQMLAP

PRCC

46

Q92733
QPPQRPPPPTGLMVK

SYNJ2

1106

O15056
PNAPPTMRAPPPTAK

ALOX5

566

P09917
ASLPMSPLAKPPPQA

PRR36

996

Q9H6K5
PQPPPPSPPMKLELK

PRR14

271

Q9BWN1
VPPKPSYLQMPRMPP

FGD1

161

P98174
QKSPATAPKPMPPRP

ARHGAP1

221

Q07960
TAPKPMPPRPPLPNQ

ARHGAP1

226

Q07960
PPCLLPPPQMPVLAA

MRGPRG-AS1

51

Q2M3A8
QPLPPAPLAMPHIKP

RERE

916

Q9P2R6
APLAMPHIKPPPTTP

RERE

921

Q9P2R6
MSKQQAPPPPPQQPP

SOX9

336

P48436
PPSLQPPPALLFPMD

TEX45

56

Q8NA69
PPPNLPVSMANPLHP

SMARCC2

1131

Q8TAQ2
EPPPPPFSVNKMLPR

OCRL

176

Q01968
PLSPPQPAPTPLKMY

SREBF1

96

P36956
MPLPRKAPLNIPGTP

NCAPH

36

Q15003
DFKNTIPMVTPPPPP

CLCA4

281

Q14CN2
PLQPGLPSPAMIPKD

ERVK-25

101

P63136
SMFLPPPPPPTPSQK

XIRP2

2186

A4UGR9
PLPPSNLPASPLMKN

TRIM13

266

O60858
KPPMLQPLALPPGLS

PFAS

646

O15067
PLQPGLPSPAMIPKD

ERVK-10

101

P10266
PLQPGLPSPAMIPKD

ERVK-8

101

P63133
PLQPGLPSPAMIPKD

ERVK-11

101

Q9UQG0
ILNSIPPPPPPAMTN

SMC4

61

Q9NTJ3
MQPKIPSQPPPVPAK

SASH1

976

O94885
PTPSPKEQPPMPQDL

SGSM1

476

Q2NKQ1
MAFPEPKPRPPELPQ

WDR83

1

Q9BRX9
SPAPQPPVLPTPMAL

TOX2

406

Q96NM4
MHKQPKLLPPPATPP

SMAD5-AS1

1

Q9Y6J3
PTPPINMNPVSTLPP

ZNF652

526

Q9Y2D9
DVPPLSPLLPPMQNN

SOCS6

306

O14544
QNPPPNLPPGSLVML

SLFN5

731

Q08AF3
SLLMVKNPPPAPPQP

ZNF282

396

Q9UDV7
PPDIKPNMSALPPPP

ZMIZ1

541

Q9ULJ6
KTPQQPPVPPQRPMA

LCP2

181

Q13094